JCO 2018:Navilas® 577sを用いた効果的なレーザー虹彩切開治療

OD-OSが、Navilas®577nmでの虹彩切開治療用に新しいソフトウェアモジュールを発表

2018年10月10日 -日本・東京-2018年10月11日〜14日に東京で開催される第72回日本臨床眼科学会(JCO)に合わせて、OD-OSはNavilas®…

JOS 2018 Symposium "Navigation Laser along with OCT-Angiography"

Secure last-minute spot in Osaka, Japan

This week, our partner Acura will host a special symposium on navigated laser therapy at the The…

Shortening the Laser Photocoagulation Learning Curve With a Navigated System

Mastering this can be challenging for residents, but a navigated laser helps expedite training.

Laser photocoagulation has long been used as a first-line treatment for DME, yet several studies…

OD-OS releases major software update for Navilas 577s

OD-OS, the global leader in the development and commercialization of navigated retinal laser…

OD-OS presents novel Yellow 577nm Navilas Laser System with microsecond pulsing option at World Ophthalmic Congress in Tokyo

OD-OS, the world leader in navigated laser therapy for retinal disease management, announced today…

Multicenter Study Announced to Evaluate Novel Combination Therapy for Treatment of Diabetic Macular Edema

TREX-DME Trial to Validate Efficacy and Stability of Treatment with Navilas® Navigated Laser plus Ranibizumab

Teltow, Germany – OD-OS, the world leader in navigated laser therapy for retinal disease management,…

Navilas® Navigated Laser Plus anti-VEGF Combination Therapy for Diabetic Macular Edema Shown to Reduce Retreatment Rates by More Than 50% While Stabilizing Visual Acuity

Study Shows Novel Combination Treatment Superior to Anti-VEGF Therapy Alone

Teltow, Germany – OD-OS, the world leader in navigated laser therapy for retinal disease management,…

Learn how to make navigated laser work for you

Contact the Navilas® team